SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4f0i'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EPB_B_9CRB165_2 (EPIDIDYMAL RETINOIC ACID-BINDING PROTEIN)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 8	LEU A 511 ALA A 526 VAL A 540 VAL A 587	None	0.88A	1epbB-4f0iA: undetectable	1epbB-4f0iA: 22.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	LYS A 543 VAL A 572 MET A 591 ARG A 648	None	0.89A	1iepA-4f0iA: 27.6	1iepA-4f0iA: 36.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_B_STIB4_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	LEU A 515 LYS A 543 MET A 591 ARG A 648	None	1.01A	1opjB-4f0iA: 26.5	1opjB-4f0iA: 36.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XBB_A_STIA1_1 (TYROSINE-PROTEIN KINASE SYK)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	LEU A 515 VAL A 523 ALA A 541 GLY A 594 LEU A 656	None	0.32A	1xbbA-4f0iA: 30.5	1xbbA-4f0iA: 32.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B8J_A_SPMA653_1 (CLASS B ACID PHOSPHATASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	ASP A 673 GLY A 669 ASP A 667 THR A 677 TYR A 679	None	1.43A	2b8jA-4f0iA: 0.0	2b8jA-4f0iA: 20.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_B_1N1B502_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 GLY A 594 LEU A 656	None	0.55A	2gqgB-4f0iA: 29.6	2gqgB-4f0iA: 36.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A 523 ALA A 541 TYR A 590 MET A 591 GLY A 594 ASP A 667	None	0.75A	2wgjA-4f0iA: 33.4	2wgjA-4f0iA: 36.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 9	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 GLY A 666 ASP A 667	None	0.65A	2xp2A-4f0iA: 30.7	2xp2A-4f0iA: 39.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A 523 ALA A 541 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.43A	2y7jA-4f0iA: 17.2	2y7jA-4f0iA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	VAL A 523 ALA A 541 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.40A	2y7jB-4f0iA: 17.2	2y7jB-4f0iA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	VAL A 523 ALA A 541 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.43A	2y7jC-4f0iA: 17.2	2y7jC-4f0iA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	VAL A 523 ALA A 541 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.39A	2y7jD-4f0iA: 17.1	2y7jD-4f0iA: 22.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3AOX_A_EMHA901_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	LEU A 515 ALA A 541 VAL A 572 MET A 591 GLY A 594 LEU A 656	None	0.49A	3aoxA-4f0iA: 25.2	3aoxA-4f0iA: 37.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	LEU A 515 VAL A 523 LYS A 543 VAL A 572 LEU A 656	None	0.92A	3cs9B-4f0iA: 31.1	3cs9B-4f0iA: 36.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 11	LEU A 515 VAL A 523 ALA A 541 TYR A 590 GLY A 594 ASP A 595 LEU A 656	None	0.79A	3g0fA-4f0iA: 32.0	3g0fA-4f0iA: 35.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	LEU A 515 VAL A 523 ALA A 541 TYR A 590 GLY A 594 LEU A 656	None	0.74A	3g0fB-4f0iA: 32.6	3g0fB-4f0iA: 35.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_S_TFPS202_1 (PROTEIN S100-A4)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	SER A 711 PHE A 712 ILE A 773 PHE A 645	None	1.01A	3ko0S-4f0iA: undetectable	3ko0S-4f0iA: 17.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 11	ALA A 541 VAL A 572 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.50A	3miyA-4f0iA: 25.2	3miyA-4f0iA: 38.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	ALA A 541 PHE A 588 MET A 591 GLY A 594 LEU A 656	None	0.34A	3miyB-4f0iA: 31.8	3miyB-4f0iA: 38.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_2 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	LYS A 543 VAL A 572 MET A 591 ARG A 648	None	0.81A	3mssB-4f0iA: 27.7	3mssB-4f0iA: 36.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_2 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	VAL A 523 LYS A 543 VAL A 572 MET A 591	None	0.74A	3mssD-4f0iA: 27.6	3mssD-4f0iA: 36.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_B_1N1B2_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656	None	0.61A	3sxrB-4f0iA: 23.3	3sxrB-4f0iA: 37.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	ALA A 541 VAL A 572 PHE A 588 ASP A 595 LEU A 656	None	0.52A	3ti1A-4f0iA: 21.8	3ti1A-4f0iA: 27.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_A_DB8A601_1 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 ALA A 541 GLU A 559 VAL A 572 MET A 591 GLY A 594 LEU A 656	None	0.59A	3ue4A-4f0iA: 31.2	3ue4A-4f0iA: 36.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 GLU A 559 VAL A 572 GLY A 594 LEU A 656	None	0.73A	3ue4B-4f0iA: 31.4	3ue4B-4f0iA: 36.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 MET A 591 GLY A 594 LEU A 656	None	0.58A	3ug2A-4f0iA: 23.3	3ug2A-4f0iA: 31.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 ALA A 541 MET A 591 GLY A 594 ASP A 595 LEU A 656 GLY A 666 ASP A 667	None	0.54A	3zbfA-4f0iA: 31.7	3zbfA-4f0iA: 36.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 9	ILE A 571 MET A 586 TYR A 590 MET A 591 ILE A 665	None	0.56A	3zosA-4f0iA: 33.5	3zosA-4f0iA: 44.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	LEU A 515 ILE A 571 MET A 586 TYR A 590 MET A 591 ILE A 665	None	0.74A	3zosB-4f0iA: 33.5	3zosB-4f0iA: 44.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 9	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 ASP A 667	None	0.61A	4anqA-4f0iA: 30.8	4anqA-4f0iA: 37.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 9	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 ASP A 667	None	0.59A	4ansA-4f0iA: 30.8	4ansA-4f0iA: 37.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 5	VAL A 523 ILE A 571 TYR A 590 MET A 591 ILE A 665	None	0.48A	4c8bA-4f0iA: 26.4	4c8bA-4f0iA: 28.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	TYR A 590 MET A 591 ILE A 571	None	0.68A	4c8bB-4f0iA: 26.6	4c8bB-4f0iA: 28.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	TYR A 590 MET A 591 ILE A 665	None	0.41A	4c8bB-4f0iA: 26.6	4c8bB-4f0iA: 28.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	LEU A 515 GLY A 516 GLY A 518 VAL A 523 ALA A 541 TYR A 590	None	0.51A	4ckjA-4f0iA: 23.6	4ckjA-4f0iA: 38.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656	None	0.43A	4hjoA-4f0iA: 29.5	4hjoA-4f0iA: 31.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 GLY A 594 ASP A 595 LEU A 656 ASP A 667	None	0.74A	4mkcA-4f0iA: 30.6	4mkcA-4f0iA: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 ASP A 667	None	0.69A	4mxoA-4f0iA: 24.2	4mxoA-4f0iA: 34.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 GLY A 594 LEU A 656 ASP A 667	None	0.78A	4mxoB-4f0iA: 24.3	4mxoB-4f0iA: 34.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656 ASP A 667	None	0.72A	4mxoB-4f0iA: 24.3	4mxoB-4f0iA: 34.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 MET A 591 GLY A 594 LEU A 656	None	0.51A	4mxxB-4f0iA: 23.7	4mxxB-4f0iA: 34.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 TYR A 590 GLY A 594 LEU A 656	None	0.60A	4mxyA-4f0iA: 23.2	4mxyA-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656 ASP A 667	None	0.77A	4mxyA-4f0iA: 23.2	4mxyA-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 GLY A 594 LEU A 656	None	0.59A	4mxyB-4f0iA: 30.1	4mxyB-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656 ASP A 667	None	0.72A	4mxyB-4f0iA: 30.1	4mxyB-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 TYR A 590 GLY A 594 LEU A 656	None	0.60A	4mxzA-4f0iA: 23.2	4mxzA-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656 ASP A 667	None	0.77A	4mxzA-4f0iA: 23.2	4mxzA-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 VAL A 523 ALA A 541 LYS A 543 VAL A 572 GLY A 594 LEU A 656	None	0.59A	4mxzB-4f0iA: 30.1	4mxzB-4f0iA: 34.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 12	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 GLY A 594 LEU A 656 ASP A 667	None	0.72A	4mxzB-4f0iA: 30.1	4mxzB-4f0iA: 34.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R82_A_ACTA207_0 (OXIDOREDUCTASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 4	GLU A 614 GLY A 612 HIS A 593 ARG A 592	None	1.34A	4r82A-4f0iA: undetectable 4r82B-4f0iA: undetectable	4r82A-4f0iA: 19.00 4r82B-4f0iA: 19.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	LEU A 515 VAL A 523 LYS A 543 ARG A 648	None	0.72A	4tyjA-4f0iA: 31.6	4tyjA-4f0iA: 39.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 6	VAL A 523 LYS A 543 ILE A 571 ARG A 648 ILE A 665	None	0.84A	4tyjA-4f0iA: 31.6	4tyjA-4f0iA: 39.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 10	LEU A 515 VAL A 523 LEU A 566 ILE A 571 VAL A 572 TYR A 590 ILE A 665	None	0.88A	4u0iA-4f0iA: 33.9	4u0iA-4f0iA: 36.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 10	VAL A 523 LEU A 566 ILE A 571 VAL A 572 TYR A 590 ARG A 648 ILE A 665	None	1.04A	4u0iA-4f0iA: 33.9	4u0iA-4f0iA: 36.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	9 / 11	LEU A 515 VAL A 523 ALA A 541 TYR A 590 MET A 591 GLY A 594 ASN A 654 LEU A 656 ASP A 667	None	0.77A	4u5jA-4f0iA: 24.5	4u5jA-4f0iA: 33.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 9	LEU A 515 VAL A 523 ALA A 541 TYR A 590 MET A 591 GLY A 594 LEU A 656	None	0.50A	4u5jB-4f0iA: 24.5	4u5jB-4f0iA: 33.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 9	LEU A 515 VAL A 523 LYS A 543 TYR A 590 ARG A 648 LEU A 656 ILE A 665	None	0.88A	4v01A-4f0iA: 26.5	4v01A-4f0iA: 38.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	LEU A 515 VAL A 523 TYR A 590 ARG A 648 LEU A 656 ILE A 665	None	0.92A	4v01B-4f0iA: 26.4	4v01B-4f0iA: 38.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 8	LYS A 543 ARG A 648 LEU A 656 ILE A 665	None	0.77A	4v04A-4f0iA: 25.8	4v04A-4f0iA: 38.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	LEU A 515 VAL A 523 LYS A 543 TYR A 590 LEU A 656 ILE A 665	None	0.87A	4v04B-4f0iA: 25.6	4v04B-4f0iA: 38.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 11	LEU A 515 ALA A 541 MET A 591 GLY A 594 ASN A 654 LEU A 656	None	0.44A	4wa9A-4f0iA: 27.5	4wa9A-4f0iA: 36.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_B_AXIB9000_1 (TYROSINE-PROTEIN KINASE ABL1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	VAL A 523 ALA A 541 LYS A 543 MET A 591 GLY A 594 ASN A 654 LEU A 656	None	0.70A	4wa9B-4f0iA: 24.6	4wa9B-4f0iA: 36.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_C_ANWC601_0 (RHODOPSIN KINASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	LEU A 515 ALA A 541 MET A 591 LEU A 656	None	0.64A	4wboC-4f0iA: 16.2	4wboC-4f0iA: 20.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	LEU A 515 ALA A 541 VAL A 572 TYR A 590 MET A 591 GLY A 594 LEU A 656	None	0.60A	4xliA-4f0iA: 24.9	4xliA-4f0iA: 36.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 9	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 GLY A 666 ASP A 667	None	0.59A	5aaaA-4f0iA: 31.2	5aaaA-4f0iA: 39.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 10	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 GLY A 666 ASP A 667	None	0.59A	5aabA-4f0iA: 30.9	5aabA-4f0iA: 39.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	8 / 10	LEU A 515 VAL A 523 ALA A 541 MET A 591 GLY A 594 LEU A 656 GLY A 666 ASP A 667	None	0.65A	5aacA-4f0iA: 24.5	5aacA-4f0iA: 39.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 515 VAL A 523 ALA A 541 GLY A 594 LEU A 656 GLY A 666	None	0.59A	5h2uA-4f0iA: 23.2	5h2uA-4f0iA: 33.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 515 VAL A 523 ALA A 541 GLY A 594 LEU A 656 GLY A 666	None	0.58A	5h2uB-4f0iA: 29.2	5h2uB-4f0iA: 33.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_C_1N1C501_1 (PROTEIN-TYROSINE KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	LEU A 515 ALA A 541 GLY A 594 LEU A 656 GLY A 666	None	0.51A	5h2uC-4f0iA: 23.3	5h2uC-4f0iA: 33.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_D_1N1D504_1 (PROTEIN-TYROSINE KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 515 VAL A 523 ALA A 541 GLY A 594 LEU A 656 GLY A 666	None	0.56A	5h2uD-4f0iA: 29.2	5h2uD-4f0iA: 33.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ERYA404_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	GLY A 723 ASP A 649 ILE A 690 ARG A 691	None	0.90A	5iwuA-4f0iA: 4.2	5iwuA-4f0iA: 23.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 516 GLY A 518 GLY A 521 VAL A 523	None	0.25A	5izjB-4f0iA: 15.0	5izjB-4f0iA: 23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	GLY A 516 VAL A 523 ALA A 541 VAL A 572 PHE A 588 ASP A 595 LEU A 656	None	0.83A	5l2iA-4f0iA: 6.5	5l2iA-4f0iA: 27.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 12	GLY A 516 VAL A 523 ALA A 541 VAL A 572 PHE A 588 ASP A 595 LEU A 656	None	0.91A	5l2tA-4f0iA: 21.9	5l2tA-4f0iA: 27.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 10	LEU A 515 VAL A 523 ALA A 541 VAL A 572 TYR A 590 LEU A 656	None	0.80A	5n3hA-4f0iA: 15.0	5n3hA-4f0iA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_2 (WEE1-LIKE PROTEIN KINASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 4	VAL A 523 LYS A 543 VAL A 572 ASN A 654	None	0.62A	5vc3A-4f0iA: 16.1	5vc3A-4f0iA: 25.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	LEU A 515 ALA A 541 LYS A 543 VAL A 572 GLY A 594 GLY A 666	None	1.03A	5vcvA-4f0iA: 15.6	5vcvA-4f0iA: 26.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XV7_A_EMHA705_1 (SERINE-ARGININE (SR) PROTEIN KINASE 1)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	LEU A 515 GLY A 516 VAL A 523 ALA A 541 PHE A 588	None	0.25A	5xv7A-4f0iA: 20.1	5xv7A-4f0iA: 14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CJK_C_ACTC301_0 (IMMUNOGLOBULIN FAB LIGHT CHAIN)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 4	VAL A 572 GLY A 666 ASP A 667 ASP A 595	None	1.27A	6cjkC-4f0iA: undetectable	6cjkC-4f0iA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EF6_A_ACTA405_0 (AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 6	THR A 704 PRO A 767 GLN A 768 ARG A 770	None	1.20A	6ef6A-4f0iA: undetectable	6ef6A-4f0iA: 21.35

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EPB_B_9CRB165_2","EPIDIDYMAL RETINOIC ACID-BINDING PROTEIN","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LEU A 511;ALA A 526;VAL A 540;VAL A 587","None","0.88A","1epbB-4f0iA:undetectable","1epbB-4f0iA:22.41"],["1IEP_A_STIA201_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LYS A 543;VAL A 572;MET A 591;ARG A 648","None","0.89A","1iepA-4f0iA:27.6","1iepA-4f0iA:36.71"],["1OPJ_B_STIB4_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LEU A 515;LYS A 543;MET A 591;ARG A 648","None","1.01A","1opjB-4f0iA:26.5","1opjB-4f0iA:36.71"],["1XBB_A_STIA1_1","TYROSINE-PROTEIN KINASE SYK","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"LEU A 515;VAL A 523;ALA A 541;GLY A 594;LEU A 656","None","0.32A","1xbbA-4f0iA:30.5","1xbbA-4f0iA:32.91"],["2B8J_A_SPMA653_1","CLASS B ACID PHOSPHATASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ASP A 673;GLY A 669;ASP A 667;THR A 677;TYR A 679","None","1.43A","2b8jA-4f0iA:0.0","2b8jA-4f0iA:20.59"],["2GQG_B_1N1B502_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;GLY A 594;LEU A 656","None","0.55A","2gqgB-4f0iA:29.6","2gqgB-4f0iA:36.54"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 523;ALA A 541;TYR A 590;MET A 591;GLY A 594;ASP A 667","None","0.75A","2wgjA-4f0iA:33.4","2wgjA-4f0iA:36.64"],["2XP2_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;GLY A 666;ASP A 667","None","0.65A","2xp2A-4f0iA:30.7","2xp2A-4f0iA:39.26"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 523;ALA A 541;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.43A","2y7jA-4f0iA:17.2","2y7jA-4f0iA:22.76"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 523;ALA A 541;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.40A","2y7jB-4f0iA:17.2","2y7jB-4f0iA:22.76"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 523;ALA A 541;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.43A","2y7jC-4f0iA:17.2","2y7jC-4f0iA:22.76"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A 523;ALA A 541;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.39A","2y7jD-4f0iA:17.1","2y7jD-4f0iA:22.76"],["3AOX_A_EMHA901_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;ALA A 541;VAL A 572;MET A 591;GLY A 594;LEU A 656","None","0.49A","3aoxA-4f0iA:25.2","3aoxA-4f0iA:37.32"],["3CS9_B_NILB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"LEU A 515;VAL A 523;LYS A 543;VAL A 572;LEU A 656","None","0.92A","3cs9B-4f0iA:31.1","3cs9B-4f0iA:36.66"],["3G0F_A_B49A9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;TYR A 590;GLY A 594;ASP A 595;LEU A 656","None","0.79A","3g0fA-4f0iA:32.0","3g0fA-4f0iA:35.36"],["3G0F_B_B49B9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;TYR A 590;GLY A 594;LEU A 656","None","0.74A","3g0fB-4f0iA:32.6","3g0fB-4f0iA:35.36"],["3KO0_S_TFPS202_1","PROTEIN S100-A4","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"SER A 711;PHE A 712;ILE A 773;PHE A 645","None","1.01A","3ko0S-4f0iA:undetectable","3ko0S-4f0iA:17.20"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A 541;VAL A 572;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.50A","3miyA-4f0iA:25.2","3miyA-4f0iA:38.18"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A 541;PHE A 588;MET A 591;GLY A 594;LEU A 656","None","0.34A","3miyB-4f0iA:31.8","3miyB-4f0iA:38.18"],["3MSS_B_STIB1_2","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LYS A 543;VAL A 572;MET A 591;ARG A 648","None","0.81A","3mssB-4f0iA:27.7","3mssB-4f0iA:36.71"],["3MSS_D_STID1_2","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"VAL A 523;LYS A 543;VAL A 572;MET A 591","None","0.74A","3mssD-4f0iA:27.6","3mssD-4f0iA:36.71"],["3SXR_B_1N1B2_1","CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656","None","0.61A","3sxrB-4f0iA:23.3","3sxrB-4f0iA:37.33"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A 541;VAL A 572;PHE A 588;ASP A 595;LEU A 656","None","0.52A","3ti1A-4f0iA:21.8","3ti1A-4f0iA:27.49"],["3UE4_A_DB8A601_1","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;ALA A 541;GLU A 559;VAL A 572;MET A 591;GLY A 594;LEU A 656","None","0.59A","3ue4A-4f0iA:31.2","3ue4A-4f0iA:36.74"],["3UE4_B_DB8B601_1","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;GLU A 559;VAL A 572;GLY A 594;LEU A 656","None","0.73A","3ue4B-4f0iA:31.4","3ue4B-4f0iA:36.74"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;MET A 591;GLY A 594;LEU A 656","None","0.58A","3ug2A-4f0iA:23.3","3ug2A-4f0iA:31.16"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;ALA A 541;MET A 591;GLY A 594;ASP A 595;LEU A 656;GLY A 666;ASP A 667","None","0.54A","3zbfA-4f0iA:31.7","3zbfA-4f0iA:36.25"],["3ZOS_A_0LIA1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ILE A 571;MET A 586;TYR A 590;MET A 591;ILE A 665","None","0.56A","3zosA-4f0iA:33.5","3zosA-4f0iA:44.86"],["3ZOS_B_0LIB1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;ILE A 571;MET A 586;TYR A 590;MET A 591;ILE A 665","None","0.74A","3zosB-4f0iA:33.5","3zosB-4f0iA:44.86"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;ASP A 667","None","0.61A","4anqA-4f0iA:30.8","4anqA-4f0iA:37.24"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;ASP A 667","None","0.59A","4ansA-4f0iA:30.8","4ansA-4f0iA:37.24"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A 523;ILE A 571;TYR A 590;MET A 591;ILE A 665","None","0.48A","4c8bA-4f0iA:26.4","4c8bA-4f0iA:28.17"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",3,"TYR A 590;MET A 591;ILE A 571","None","0.68A","4c8bB-4f0iA:26.6","4c8bB-4f0iA:28.17"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",3,"TYR A 590;MET A 591;ILE A 665","None","0.41A","4c8bB-4f0iA:26.6","4c8bB-4f0iA:28.17"],["4CKJ_A_ADNA2014_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;GLY A 516;GLY A 518;VAL A 523;ALA A 541;TYR A 590","None","0.51A","4ckjA-4f0iA:23.6","4ckjA-4f0iA:38.94"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656","None","0.43A","4hjoA-4f0iA:29.5","4hjoA-4f0iA:31.75"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;GLY A 594;ASP A 595;LEU A 656;ASP A 667","None","0.74A","4mkcA-4f0iA:30.6","4mkcA-4f0iA:35.42"],["4MXO_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;ASP A 667","None","0.69A","4mxoA-4f0iA:24.2","4mxoA-4f0iA:34.30"],["4MXO_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;GLY A 594;LEU A 656;ASP A 667","None","0.78A","4mxoB-4f0iA:24.3","4mxoB-4f0iA:34.30"],["4MXO_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656;ASP A 667","None","0.72A","4mxoB-4f0iA:24.3","4mxoB-4f0iA:34.30"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;MET A 591;GLY A 594;LEU A 656","None","0.51A","4mxxB-4f0iA:23.7","4mxxB-4f0iA:34.30"],["4MXY_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;TYR A 590;GLY A 594;LEU A 656","None","0.60A","4mxyA-4f0iA:23.2","4mxyA-4f0iA:34.63"],["4MXY_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656;ASP A 667","None","0.77A","4mxyA-4f0iA:23.2","4mxyA-4f0iA:34.63"],["4MXY_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;GLY A 594;LEU A 656","None","0.59A","4mxyB-4f0iA:30.1","4mxyB-4f0iA:34.63"],["4MXY_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656;ASP A 667","None","0.72A","4mxyB-4f0iA:30.1","4mxyB-4f0iA:34.63"],["4MXZ_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;TYR A 590;GLY A 594;LEU A 656","None","0.60A","4mxzA-4f0iA:23.2","4mxzA-4f0iA:34.63"],["4MXZ_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656;ASP A 667","None","0.77A","4mxzA-4f0iA:23.2","4mxzA-4f0iA:34.63"],["4MXZ_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;LYS A 543;VAL A 572;GLY A 594;LEU A 656","None","0.59A","4mxzB-4f0iA:30.1","4mxzB-4f0iA:34.63"],["4MXZ_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;GLY A 594;LEU A 656;ASP A 667","None","0.72A","4mxzB-4f0iA:30.1","4mxzB-4f0iA:34.63"],["4R82_A_ACTA207_0","OXIDOREDUCTASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"GLU A 614;GLY A 612;HIS A 593;ARG A 592","None","1.34A","4r82A-4f0iA:undetectable;4r82B-4f0iA:undetectable","4r82A-4f0iA:19.00;4r82B-4f0iA:19.00"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LEU A 515;VAL A 523;LYS A 543;ARG A 648","None","0.72A","4tyjA-4f0iA:31.6","4tyjA-4f0iA:39.24"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A 523;LYS A 543;ILE A 571;ARG A 648;ILE A 665","None","0.84A","4tyjA-4f0iA:31.6","4tyjA-4f0iA:39.24"],["4U0I_A_0LIA1001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;LEU A 566;ILE A 571;VAL A 572;TYR A 590;ILE A 665","None","0.88A","4u0iA-4f0iA:33.9","4u0iA-4f0iA:36.73"],["4U0I_A_0LIA1001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A 523;LEU A 566;ILE A 571;VAL A 572;TYR A 590;ARG A 648;ILE A 665","None","1.04A","4u0iA-4f0iA:33.9","4u0iA-4f0iA:36.73"],["4U5J_A_RXTA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",9,"LEU A 515;VAL A 523;ALA A 541;TYR A 590;MET A 591;GLY A 594;ASN A 654;LEU A 656;ASP A 667","None","0.77A","4u5jA-4f0iA:24.5","4u5jA-4f0iA:33.98"],["4U5J_B_RXTB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;ALA A 541;TYR A 590;MET A 591;GLY A 594;LEU A 656","None","0.50A","4u5jB-4f0iA:24.5","4u5jB-4f0iA:33.98"],["4V01_A_0LIA1776_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;VAL A 523;LYS A 543;TYR A 590;ARG A 648;LEU A 656;ILE A 665","None","0.88A","4v01A-4f0iA:26.5","4v01A-4f0iA:38.10"],["4V01_B_0LIB1770_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;TYR A 590;ARG A 648;LEU A 656;ILE A 665","None","0.92A","4v01B-4f0iA:26.4","4v01B-4f0iA:38.10"],["4V04_A_0LIA1772_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LYS A 543;ARG A 648;LEU A 656;ILE A 665","None","0.77A","4v04A-4f0iA:25.8","4v04A-4f0iA:38.10"],["4V04_B_0LIB1771_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;LYS A 543;TYR A 590;LEU A 656;ILE A 665","None","0.87A","4v04B-4f0iA:25.6","4v04B-4f0iA:38.10"],["4WA9_A_AXIA9000_1","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;ALA A 541;MET A 591;GLY A 594;ASN A 654;LEU A 656","None","0.44A","4wa9A-4f0iA:27.5","4wa9A-4f0iA:36.86"],["4WA9_B_AXIB9000_1","TYROSINE-PROTEIN KINASE ABL1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A 523;ALA A 541;LYS A 543;MET A 591;GLY A 594;ASN A 654;LEU A 656","None","0.70A","4wa9B-4f0iA:24.6","4wa9B-4f0iA:36.86"],["4WBO_C_ANWC601_0","RHODOPSIN KINASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"LEU A 515;ALA A 541;MET A 591;LEU A 656","None","0.64A","4wboC-4f0iA:16.2","4wboC-4f0iA:20.57"],["4XLI_A_1N1A601_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"LEU A 515;ALA A 541;VAL A 572;TYR A 590;MET A 591;GLY A 594;LEU A 656","None","0.60A","4xliA-4f0iA:24.9","4xliA-4f0iA:36.82"],["5AAA_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;GLY A 666;ASP A 667","None","0.59A","5aaaA-4f0iA:31.2","5aaaA-4f0iA:39.26"],["5AAB_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;GLY A 666;ASP A 667","None","0.59A","5aabA-4f0iA:30.9","5aabA-4f0iA:39.26"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",8,"LEU A 515;VAL A 523;ALA A 541;MET A 591;GLY A 594;LEU A 656;GLY A 666;ASP A 667","None","0.65A","5aacA-4f0iA:24.5","5aacA-4f0iA:39.26"],["5H2U_A_1N1A501_1","PROTEIN-TYROSINE KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;GLY A 594;LEU A 656;GLY A 666","None","0.59A","5h2uA-4f0iA:23.2","5h2uA-4f0iA:33.67"],["5H2U_B_1N1B501_1","PROTEIN-TYROSINE KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;GLY A 594;LEU A 656;GLY A 666","None","0.58A","5h2uB-4f0iA:29.2","5h2uB-4f0iA:33.67"],["5H2U_C_1N1C501_1","PROTEIN-TYROSINE KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"LEU A 515;ALA A 541;GLY A 594;LEU A 656;GLY A 666","None","0.51A","5h2uC-4f0iA:23.3","5h2uC-4f0iA:33.67"],["5H2U_D_1N1D504_1","PROTEIN-TYROSINE KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;GLY A 594;LEU A 656;GLY A 666","None","0.56A","5h2uD-4f0iA:29.2","5h2uD-4f0iA:33.67"],["5IWU_A_ERYA404_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"GLY A 723;ASP A 649;ILE A 690;ARG A 691","None","0.90A","5iwuA-4f0iA:4.2","5iwuA-4f0iA:23.99"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"GLY A 516;GLY A 518;GLY A 521;VAL A 523","None","0.25A","5izjB-4f0iA:15.0","5izjB-4f0iA:23.62"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"GLY A 516;VAL A 523;ALA A 541;VAL A 572;PHE A 588;ASP A 595;LEU A 656","None","0.83A","5l2iA-4f0iA:6.5","5l2iA-4f0iA:27.86"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"GLY A 516;VAL A 523;ALA A 541;VAL A 572;PHE A 588;ASP A 595;LEU A 656","None","0.91A","5l2tA-4f0iA:21.9","5l2tA-4f0iA:27.86"],["5N3H_A_NCAA401_0","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;VAL A 523;ALA A 541;VAL A 572;TYR A 590;LEU A 656","None","0.80A","5n3hA-4f0iA:15.0","5n3hA-4f0iA:23.44"],["5VC3_A_DB8A601_2","WEE1-LIKE PROTEIN KINASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"VAL A 523;LYS A 543;VAL A 572;ASN A 654","None","0.62A","5vc3A-4f0iA:16.1","5vc3A-4f0iA:25.62"],["5VCV_A_1N1A404_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"LEU A 515;ALA A 541;LYS A 543;VAL A 572;GLY A 594;GLY A 666","None","1.03A","5vcvA-4f0iA:15.6","5vcvA-4f0iA:26.36"],["5XV7_A_EMHA705_1","SERINE-ARGININE (SR) PROTEIN KINASE 1","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"LEU A 515;GLY A 516;VAL A 523;ALA A 541;PHE A 588","None","0.25A","5xv7A-4f0iA:20.1","5xv7A-4f0iA:14.47"],["6CJK_C_ACTC301_0","IMMUNOGLOBULIN FAB LIGHT CHAIN","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"VAL A 572;GLY A 666;ASP A 667;ASP A 595","None","1.27A","6cjkC-4f0iA:undetectable","6cjkC-4f0iA:20.20"],["6EF6_A_ACTA405_0","AMINOGLYCOSIDE PHOSPHOTRANSFERASE","4f0i","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","Homo sapiens",4,"THR A 704;PRO A 767;GLN A 768;ARG A 770","None","1.20A","6ef6A-4f0iA:undetectable","6ef6A-4f0iA:21.35"]]